Login / Signup

Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients.

Justin C TosseyZeinab El BoghdadlyErica E ReedJennifer Dela-PenaKelci E CoeSherry N WilliamsLynn C Wardlow
Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
The use of PO FQ may be considered for the definitive treatment of uncomplicated Enterobacterales BSI in cancer patients.
Keyphrases
  • gram negative
  • multidrug resistant
  • squamous cell carcinoma
  • radiation therapy
  • combination therapy